These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? Schreier MH; Baumann G; Zenke G Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818 [No Abstract] [Full Text] [Related]
4. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Schreiber SL Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904 [TBL] [Abstract][Full Text] [Related]
5. Immunophilins in protein folding and immunosuppression. Fruman DA; Burakoff SJ; Bierer BE FASEB J; 1994 Apr; 8(6):391-400. PubMed ID: 7513288 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. Bierer BE Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531 [No Abstract] [Full Text] [Related]
7. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Kunz J; Hall MN Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398 [TBL] [Abstract][Full Text] [Related]
8. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. Bell A; Roberts HC; Chappell LH Gen Pharmacol; 1996 Sep; 27(6):963-71. PubMed ID: 8909976 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Liu J; Farmer JD; Lane WS; Friedman J; Weissman I; Schreiber SL Cell; 1991 Aug; 66(4):807-15. PubMed ID: 1715244 [TBL] [Abstract][Full Text] [Related]
12. FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond. Siekierka JJ; Sigal NH Curr Opin Immunol; 1992 Oct; 4(5):548-52. PubMed ID: 1384551 [TBL] [Abstract][Full Text] [Related]
14. Do we know the site of action of cyclosporin? Erlanger BF Immunol Today; 1992 Dec; 13(12):487-90. PubMed ID: 1334415 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. Lane BC; Miller LN; Kawai M; Or YS; Wiedeman P; Holzman TF; Luly JR Transplant Proc; 1993 Feb; 25(1 Pt 1):644-6. PubMed ID: 7679829 [No Abstract] [Full Text] [Related]
16. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Bell A; Wernli B; Franklin RM Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696 [TBL] [Abstract][Full Text] [Related]
17. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks? High KP; Handschumacher RE Infect Agents Dis; 1992 Jun; 1(3):121-35. PubMed ID: 1285413 [TBL] [Abstract][Full Text] [Related]
18. Leukocyte chemotactic activity of FKBP and inhibition by FK506. Leiva MC; Lyttle CR Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of calcineurin by a novel FK-506-binding protein. Sewell TJ; Lam E; Martin MM; Leszyk J; Weidner J; Calaycay J; Griffin P; Williams H; Hung S; Cryan J J Biol Chem; 1994 Aug; 269(33):21094-102. PubMed ID: 7520438 [TBL] [Abstract][Full Text] [Related]
20. Specific interaction of the cyclophilin-cyclosporin complex with the B subunit of calcineurin. Li W; Handschumacher RE J Biol Chem; 1993 Jul; 268(19):14040-4. PubMed ID: 7686148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]